These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7811008)

  • 1. Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones.
    Revel V; Cambau E; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1991-6. PubMed ID: 7811008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria.
    Cambau E; Sougakoff W; Jarlier V
    FEMS Microbiol Lett; 1994 Feb; 116(1):49-54. PubMed ID: 8132154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
    Guillemin I; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2084-8. PubMed ID: 9687411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
    Bebear CM; Bové JM; Bebear C; Renaudin J
    Antimicrob Agents Chemother; 1997 Feb; 41(2):269-73. PubMed ID: 9021178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
    Cambau E; Sougakoff W; Besson M; Truffot-Pernot C; Grosset J; Jarlier V
    J Infect Dis; 1994 Aug; 170(2):479-83. PubMed ID: 8035042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
    Weigel LM; Steward CD; Tenover FC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.
    Alangaden GJ; Manavathu EK; Vakulenko SB; Zvonok NM; Lerner SA
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1700-3. PubMed ID: 7486904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.
    Okuda J; Hayakawa E; Nishibuchi M; Nishino T
    Antimicrob Agents Chemother; 1999 May; 43(5):1156-62. PubMed ID: 10223929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis.
    Banerjee SK; Bhatt K; Rana S; Misra P; Chakraborti PK
    Biochem Biophys Res Commun; 1996 Sep; 226(2):362-8. PubMed ID: 8806641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.
    Dessus-Babus S; Bébéar CM; Charron A; Bébéar C; de Barbeyrac B
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2474-81. PubMed ID: 9756744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp.
    Maurin M; Abergel C; Raoult D
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2098-105. PubMed ID: 11408229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.